Tag Archives: Gilead

HIV drugmakers ViiV, Gilead top 2018 pharma reputation survey

Pharma’s reputation is holding steady. That’s according to the annual patient group opinion report from PatientView, which found 41% who rated the pharma industry reputation as “excellent” or “good” in 2018, compared with a similar 43% in 2017. Fifty-three percent of patient groups also rated the industry as excellent or good for the making of… Read More »

Novartis changes NICE's mind on Kymriah, giving CAR-T rival Gilead some company

Payer coverage is key to Novartis’ plan to get Kymriah going, and the company is going to be getting some more of that. England’s cost watchdog, the National Institute for Health and Care Excellence (NICE), has recommended the CAR-T med to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) through its Cancer… Read More »